Identifying pathogenic proteins leads to potential new treatments for diseases such as diabetes.

Published Date: 02 Mar 2023

New research has identified hundreds of proteins that can lead to the development of metabolic diseases, such as type 2 diabetes mellitus, and therefore have treatment potential.

Read Full News

Latest News

Acid Blockers May Worsen Gastro Effects of Weight-Loss Drugs

The dual-medication group shows a significantly higher risk for several conditions.

Longer Abstinence May Reduce Sperm Quality Over Time

Prolonged sperm storage may reduce motility and vitality through oxidative stress and DNA damage, thereby affecting fertility.

Why Patients Stop Treatment and How Clinicians Can Help

Medication adherence often declines over time, but targeted communication and simpler regimens may help improve long-term treatment outcomes.

Want to Know What Caused Cushing? Urine Tests Can Help

Urinary free cortisol expressed as times above the upper limit of normal is a strong discriminator between ectopic ACTH-dependent and pituitary Cushing syndrome, according to a Spanish study.

Hidden Sugar Traps Patients With Diabetes Should Recognize

Food labels are often misleading when it comes to glycemic impacts.

Previous Pregnancy Signals Lower Folic Acid Use

Women with previous pregnancies are consistently less likely than first-time mothers to take folic acid supplements before conception and during early pregnancy, a meta-analysis shows.

Todays Updates

Only 1 in 4 Eligible Adults Receive Lung Screening

Complicated eligibility rules, stigma surrounding smoking and lung cancer, and confusion about the screening process continue to keep many high-risk patients from getting screened.

Low PSA May Not Fully Predict Survival in Prostate Cancer

A recent post hoc analysis assesses whether PSA changes can predict survival outcomes in patients with metastatic or very high risk nonmetastatic prostate cancer.

FDA Warns of Secondary Blood Cancer Risk With Tazverik

The FDA says the increased risk of hematologic secondary primary malignancies with tazemetostat now outweighs the benefits of the drug; Ipsen pulls it from the market.

FDA Approves Next-Gen Agent for Mantle Cell Lymphoma

The BCL-2 inhibitor was granted accelerated approval based on findings from the phase 1/2 BGB-11417-201 study.

Todays Updates

Only 1 in 4 Eligible Adults Receive Lung Screening

Complicated eligibility rules, stigma surrounding smoking and lung cancer, and confusion about the screening process continue to keep many high-risk patients from getting screened.

Low PSA May Not Fully Predict Survival in Prostate Cancer

A recent post hoc analysis assesses whether PSA changes can predict survival outcomes in patients with metastatic or very high risk nonmetastatic prostate cancer.

FDA Warns of Secondary Blood Cancer Risk With Tazverik

The FDA says the increased risk of hematologic secondary primary malignancies with tazemetostat now outweighs the benefits of the drug; Ipsen pulls it from the market.

FDA Approves Next-Gen Agent for Mantle Cell Lymphoma

The BCL-2 inhibitor was granted accelerated approval based on findings from the phase 1/2 BGB-11417-201 study.

Latest News

The dual-medication group shows a significantly higher risk for several conditions.

Prolonged sperm storage may reduce motility and vitality through oxidative stress and DNA damage, thereby affecting fertility.

Medication adherence often declines over time, but targeted communication and simpler regimens may help improve long-term treatment outcomes.

Urinary free cortisol expressed as times above the upper limit of normal is a strong discriminator between ectopic ACTH-dependent and pituitary Cushing syndrome, according to a Spanish study.

Food labels are often misleading when it comes to glycemic impacts.

Women with previous pregnancies are consistently less likely than first-time mothers to take folic acid supplements before conception and during early pregnancy, a meta-analysis shows.

News All Time

GLP-1 Pill Showdown; $35 Insulin Cap Success; Preterm Births Tied to Plastics

News and commentary from the endocrinology world

Further Doubt on Heart-Healthiness of Calcium Supplements

Recurrent cardiovascular events increased in a large cohort study

Call to Integrate Obesity Management With Surgery, GLP-1s Into Cancer Care

"Most effective therapies" underutilized, say authors, but oncologist cites lack of quality data

Are GLP-1 Drugs Linked to Erectile Dysfunction?

Real-world study in type 2 diabetes suggests possible association, but more research is needed

Drug Manufacturer Coupon Use; Cholesterol Targets for Secondary Prevention

Also in TTHealthWatch: deprescribing levothyroxine

New GLP-1 Side Effect? Highest-Burnout Specialties; Trump's Psychedelic Plan

Health news and commentary gathered by MedPage Today staff

Meal Monotony for Weight Loss; Genes Explain GLP-1 Response; Menopause Drug Boom

News and commentary from the endocrinology world

Mobile Intervention Helps Moms With Obesity Reduce Gestational Weight Gain

Intervention uses a smartphone app to promote healthy eating and increased activity

FDA Takes Steps to Expand Testosterone for Men's Libido

Agency last year removed boxed warning about risks for heart attack and stroke

GLP-1s and Muscle Loss; 'Ozempic Personality'; Acromegaly and Cancer Risk

News and commentary from the endocrinology world

Study Warns of High-Risk Group for Fatal Liver Disease

Risky drinking and obesity "contribute synergistically" to rising rates of liver disease, death

'Ozempic Personality': Is Emotional Flattening Another Side Effect of GLP-1s?

Some patients have reported 'a dulled response' to sources of pleasure beyond food

Can Endoscopic Procedure Slow Post-GLP-1 Weight Rebound?

In pilot trial, duodenal mucosal resurfacing shows signal of benefit

GLP-1 Pill Spurred New Scripts; 'Food Noise' Phenomenon; Diabetes and Dementia

News and commentary from the endocrinology world

FDA Intensifies Crackdown on GLP-1 Compounding

Agency proposal would exclude semaglutide, tirzepatide, and liraglutide from 503B bulks list

GLP-1 Drug Improved Motivation in Major Depressive Disorder

Findings have implications for treating neuropsychiatric disorders involving reward dysfunction

Recommended News For You

PNH With Extravascular Hemolysis Approves Factor D Inhibitor.

Through the activation of bitter taste receptors, lidocaine has the potential to kill some cancer cells.

Studies point to redlining as a 'perfect storm' for breast cancer

First-Line Combination for Bladder Cancer Not Eligible for Cisplatin Just Misses Positive Outcome.

The response of bipolar patients to lithium may be predicted by ancestry.

O. A. J. Simpson passes away from cancer.

Waiting for a Sharp Increase in Prostate Cancer Cases.

Recommended Articles For You

Unlocking the Mysteries of Lymphoblastic Lymphoma: A Journey Into the Unknown 

Obesity is a major risk factor for cancer 

The Technological Revolution in Precision Oncology and Tumor Microenvironment Therapy 

Innovative Marketing Strategies for Oncology Drugs: A Clinician’s Take on Digital and B2B Trends 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

More Positive Survival Data in Lung Cancer With Perioperative Therapy

2.

Good News for CAR-T Therapy; Liquid Biopsy Progress; Anti-Psychotic for Brain Cancer

3.

Sickle Cell Disease Drug Pulled From Global Markets

4.

Biomarker panel offers hope for early pancreatic cancer detection

5.

Having dense breasts is linked to cancer, but advice about breast density can depend on where you live

1.

Acrochordon: What It Is, Causes, And How To Manage This Skin Condition

2.

Understanding Thrombin Time: What It Is and How It Can Help Diagnose Blood Clotting Disorders

3.

Unlocking the Mysteries of ICD 10 Code Normocytic Anemia

4.

The latest research on Iron Binding Capacity: The Little-Known Factor That Could Impact Your Health v

5.

Emerging and Innovative Therapies in Cancer Treatment and Post-Surgical Care

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I

2.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

3.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part V

4.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

5.

Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot